Bladder Cancer Lawsuit News and Information
Actos Lawsuit
Side effects of the popular diabetes drug Actos may increase the risk of bladder cancer. Health regulators in some European countries have suspended sales of the drug and the FDA required new warnings about the potential risk of bladder cancer from Actos in June 2011. STATUS OF ACTOS BLADDER CANCER LAWSUITS: As a result of [...]
All Articles Tagged With: "Bladder Cancer"
New Diabetes Drug that Includes Actos Rejected by FDA
The FDA has rejected approval of two new diabetes drugs developed by Takeda Pharmaceuticals, including a drug that contains a combination of a new treatment and Actos, a current diabetes drug that has been linked to a risk of bladder cancer.
Bladder Cancer Risk Leads to Actos Limitations in Ontario
The Canadian province of Ontario is limiting patient access to Actos, due to the risk of bladder cancer associated with long-term use of the diabetes drug.
Actos Warning Over Bladder Cancer Risk Added in Canada
Canadian health officials have issued new warnings that the diabetes drug Actos may increase the risk of bladder cancer.
Actos Attorneys Appointed Leadership Roles in Bladder Cancer Litigation
U.S. District Judge Rebecca Doherty, who is presiding over all federal Actos bladder cancer lawsuits, has appointed a number of attorneys to serve in various leadership roles in the recently formed multidistrict litigation (MDL).
Actos Lawyers Seeking Leadership Roles in Federal MDL
The judge presiding over all federal Actos bladder cancer lawsuits has invited any lawyers interested in serving on a committee or in a leadership role within the consolidated multidistrict litigation (MDL), to submit certain information on their qualifications before a hearing scheduled for next month.
Metal-on-Metal Hip Replacements May Be Linked to Cancer Risk: Report
A study currently underway is expected to reveal that side effects of metal-on-metal hip replacements may cause genetic damage, which could lead to an increased risk of cancer.
Lawsuit Over Bladder Cancer from Actos Remanded to California Court
A California man has won a battle to keep his Actos lawsuit over bladder cancer in California state court, which could impact dozens of other cases involved in the Actos litigation.
Actos Concerns Contribute to Takeda Cutting Work Force
Takeda Pharmaceuticals has announced plans to cut 2,800 jobs in the United States and Europe, amid concerns over Actos sales and its recent acquisition of the Swiss drug company Nycomed.
Despite Bladder Cancer Risk, Actos Still Valid Treatment: European Comm.
European health officials have determined that Actos is still a valid treatment for diabetes, despite serious concerns about the potential risk of bladder cancer from Actos.
Lawsuits Over Actos and Bladder Cancer Coordinated in Calif. State Court
All Actos lawsuits filed in California state court by individuals who developed bladder cancer after taking the popular type 2 diabetes drug will be consolidated and coordinated during pretrial proceedings.
Contact a Lawyer
Submit information about your potential case to be reviewed by an attorney.
